Skip to content

Add on effect of marama therapy on cervical pain.

To Explore the effect of specific marma manipulation and anatomical aspect of Greeva Bahugata Marma in the management of Cervical Spondylosis (Greeva Sandhigata Vata)- A Randomized Comparative Study. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064607
Enrollment
70
Registered
2024-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M498- Spondylopathy in diseases classified elsewhere

Interventions

None listed

Sponsors

Ch Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients irrespective of sex, presenting with signs and symptoms of Cervical Spondylosis . 2.Patient having findings of cervical spondylosis in plain Cervical X ray( AP and lat). 3.Subjects of age group 20 to 60 years will be registered in both the groups. 4.Patients fit for stimulation of marma.

Exclusion criteria

Exclusion criteria: 1.Post traumatic patients having history of fractures and dislocation of cervical and shoulder region. 2.Patients having cervical deformities, postural defects and uncontrolled diabetes, hypertension, malignancy and hepatitis. Major systemic disorders, neurodegenerative condition of spine (eg TB, malignancy)

Design outcomes

Primary

MeasureTime frame
Combined effect of Marma therapy and oral medicine for 15 days on CROM will be determined in the patient of Cervical Spondylosis.Timepoint: 15 days

Secondary

MeasureTime frame
Combined Effect of Marma Therapy & oral medicines for 15 days on Neck Disabilty Index will determined in the pateint of cervical spondylosis.Timepoint: 15 Days.

Countries

India

Contacts

Public ContactDr. Aishvarya

Ch. Brahm Prakash Aayurved Charak Sansthan

aishvarya17@gmail.com08800988254

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026